According to Zhitong Financial App, Jingjiu Health (00648) issued an announcement. On April 21, 2020, the Stock Exchange informed that it will not exercise its right to delist the company in accordance with section 6.01A (2) (b) of the listing rules, subject to further developments in the company's petition to the Securities Regulatory Commission, and may exercise its rights at a later stage in accordance with section 6.01A of the Listing Rules if it deems appropriate. The company will continue to gradually address the concerns of the Securities Regulatory Commission and the Stock Exchange.

The company is mainly engaged in medical business, and all major aspects of its business operations are carried out as usual. The Board will continue to evaluate and monitor the impact of the suspension of trading on the Group's operating and financial performance, and take appropriate measures where appropriate.